Neurocrine Biosciences
NBIX
#1321
Rank
S$21.95 B
Marketcap
S$216.89
Share price
0.17%
Change (1 day)
10.99%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): S$2.67

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is S$8.94. In 2022 the company made an earnings per share (EPS) of S$2.06 an increase over its 2021 EPS that were of S$1.22.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S$2.6729.28%
2022S$2.0669.47%
2021S$1.22-78.21%
2020S$5.59990%
2019S$0.5181.82%
2018S$0.28-113.5%
2017S-$2.090.62%
2016S-$2.0857.28%
2015S-$1.3225.61%
2014S-$1.0518.84%
2013S-$0.88-1085.71%
2012S$0.08976-89.71%
2011S$0.87-500%
2010S-$0.22-86.92%
2009S-$1.67-43.48%
2008S-$2.95-57.8%
2007S-$6.9992.58%
2006S-$3.63371.67%
2005S-$0.77-52.76%
2004S-$1.6336.56%
2003S-$1.19-70%
2002S-$3.98118.31%
2001S-$1.828.4%
2000S-$1.6848.86%
1999S-$1.13-20%
1998S-$1.41-479.31%
1997S$0.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$0.91-89.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$7.50-16.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.61 343.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S-$0.26-102.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
S-$2.60-129.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$6.64-25.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S-$9.68-208.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
S$1.96-78.06%๐Ÿ‡ฌ๐Ÿ‡ง UK